Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesInspire Medical Systems Inc

Inspire Medical Systems Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
66.53 USD -0.08 ( 0.12%)
Last update at 2026-11-05T21:00:00Z
VOLUME
1075033
Market Cap
2156.71M
P/E
16.47

Momentum Score

…

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
64.81
Low
68.95
High
52 Week Price Range
38.91
Low
147.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Inspire Medical Systems makes an implantable hypoglossal nerve stimulator for obstructive sleep apnea in patients who cannot tolerate CPAP, with regulatory approvals enabling commercial sales. Long-term growth may be driven by rising OSA diagnosis and treatment uptake, international expansion, broader clinician adoption, and incremental device improvements; the company appears positioned with a clinically supported, procedure-driven therapy.
Major risks include reliance on reimbursement and referral patterns, procedural and device-safety or regulatory setbacks, competition from noninvasive options, and sensitivity to elective-procedure volumes.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
66.61
Dividend Yield
-
Revenue TTM
898.74M
Revenue Per Share
31.04
Gross Profit TTM
774.11M
Debt / Equity
0.04
ROE
17.97%
Net Debt
-72.66M
ROCE
8.12%
Diluted EPS TTM
4.53

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 65.70M 58.45M -19.91M -44.27M -41.97M
Net income 145.42M 53.51M -21.15M -44.88M -42.04M
Selling general administrative 624.64M 434.71M 422.69M 320.69M 202.62M
Selling and marketing expenses - 94.90M 100.30M - -
Gross profit 778.76M 679.82M 528.22M 341.74M 200.12M
Reconciled depreciation 13.96M 6.55M 2.60M 1.86M 1.22M
Ebit 65.83M 58.48M -40.27M -47.59M -39.85M
Ebitda 79.79M 65.03M -40.27M -42.59M -39.84M
Depreciation and amortization 13.96M 6.55M 2.85M 5.00M 0.01M
Non operating income net other - - - 4.88M -0.08M
Operating income 50.95M 36.08M -40.27M -47.59M -39.85M
Other operating expenses 861.03M 766.72M 665.07M 455.45M 273.24M
Interest expense 0.14M 0.02M 0.00M 1.68M 2.13M
Tax provision -79.72M 4.94M 0.90M 0.61M 0.07M
Interest income 17.54M 23.25M 18.06M 5.05M 0.12M
Net interest income 17.40M 23.23M 18.06M 3.37M -2.00M
Income tax expense -79.72M 4.94M 1.25M 0.61M 0.07M
Total revenue 911.98M 802.80M 624.80M 407.86M 233.39M
Total operating expenses 727.80M 643.74M 568.49M 389.33M 239.97M
Cost of revenue 133.22M 122.99M 96.58M 66.11M 33.28M
Total other income expense net 14.74M 22.37M 20.36M 3.32M -2.12M
Net income from continuing ops 145.42M 53.51M -32.77M -44.88M -42.04M
Net income applicable to common shares - - - -44.88M -42.04M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 907.32M 808.38M 676.81M 564.88M 295.08M
Other current assets 10.40M 12.07M 9.60M 5.50M 2.66M
Total liab 126.16M 118.69M 104.30M 68.87M 66.04M
Total stockholder equity 781.16M 689.70M 572.51M 496.01M 229.05M
Other current liab 57.33M 48.20M 39.27M 33.00M 20.45M
Common stock 0.03M 0.03M 0.03M 0.03M 0.03M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings -146.49M -291.91M -345.42M -324.27M -279.39M
Other liab - - - 0.15M 0.13M
Other assets - - - 0.21M 0.20M
Cash 104.81M 150.15M 185.54M 441.59M 214.47M
Total current liabilities 96.06M 88.50M 78.11M 61.19M 41.31M
Net debt -72.66M -118.36M -160.69M -432.72M -180.68M
Short term debt 2.16M - - 1.34M 9.19M
Short long term debt - - - - 9.19M
Short long term debt total 32.16M 31.79M 24.85M 8.87M 33.78M
Other stockholder equity 927.16M 981.04M 917.11M 820.34M 508.46M
Property plant equipment - - - 17.25M 16.41M
Total current assets 583.65M 630.81M 593.74M 530.03M 268.54M
Long term investments 96.33M 71.00M 9.14M 0.00M 9.94M
Net tangible assets - - - 496.01M 229.05M
Short term investments 203.46M 295.40M 274.84M 9.82M 0.00M
Net receivables 119.69M 93.07M 89.88M 61.23M 34.18M
Long term debt - - - - 15.80M
Inventory 145.29M 80.12M 33.88M 11.89M 17.23M
Accounts payable 36.56M 38.69M 38.84M 26.85M 11.66M
Accumulated other comprehensive income 0.46M 0.54M 0.80M -0.09M -0.06M
Common stock total equity - - - 0.03M 0.03M
Retained earnings total equity - - - -324.27M -279.39M
Non currrent assets other 17.26M 11.34M 11.28M 10.71M 0.20M
Non current assets total 323.66M 177.58M 83.07M 34.84M 26.55M
Capital lease obligations 32.16M 31.79M 24.85M 7.54M 8.80M
Long term debt total - - - - 15.80M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 59.95M -113.12M -146.05M -10.50M 33.81M
Change to liabilities - - - 26.30M 11.84M
Total cashflows from investing activities 21.45M -113.12M -294.82M -19.60M 29.14M
Net borrowings - 0.00M 0.00M -24.50M -24.50M
Total cash from financing activities -183.45M -52.39M 13.95M 235.08M 14.95M
Change to operating activities - - - 9.13M 6.36M
Net income 145.42M 53.51M -21.15M -44.88M -42.04M
Change in cash -45.34M -35.39M -256.06M 227.12M 23.95M
Begin period cash flow 150.15M 185.54M 441.59M 214.47M 190.52M
End period cash flow 104.81M 150.15M 185.54M 441.59M 214.47M
Total cash from operating activities 116.98M 130.25M 24.65M 11.57M -20.12M
Issuance of capital stock - 0.00M 0.00M 243.80M 0.00M
Depreciation 13.96M 6.55M 2.85M 1.86M 1.22M
Other cashflows from investing activities - -74.00M - - -
Change to inventory -65.17M -46.23M -22.00M 5.34M -8.75M
Change to account receivables -26.23M -2.60M -30.22M -27.02M -9.24M
Sale purchase of stock -175.02M -75.00M -17.16M 3.74M 3.47M
Other cashflows from financing activities -23.04M -5.17M -17.16M 12.04M 11.48M
Change to netincome - - - 51.42M 26.23M
Capital expenditures 38.50M 39.12M 23.63M 9.10M 4.67M
Change receivables - - - -27.02M -9.24M
Cash flows other operating - - - -1.45M 0.38M
Exchange rate changes - - - - -0.02M
Cash and cash equivalents changes - - - 227.05M 23.95M
Change in working capital -87.38M -37.71M -40.78M 1.81M -6.86M
Stock based compensation 130.26M 116.01M 82.47M 51.97M 26.18M
Other non cash items 3.47M -7.51M 1.27M 0.81M 1.37M
Free cash flow 78.48M 91.12M 1.02M 2.47M -24.79M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
INSP
Inspire Medical Systems Inc		 -0.08
0.12%		 66.53 16.47 63.69 2.40 2.60 2.07 21.54
ABT
Abbott Laboratories		 -1.91
1.65%		 113.60 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -0.12
0.11%		 104.84 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -4.61
1.36%		 335.04 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 1.24
2.45%		 52.00 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

5500 Wayzata Blvd., Golden Valley, MN, United States, 55416

844 672 4357

https://www.inspiresleep.com

1333

Name Title Year Born
Mr. Timothy P. Herbert CEO, Pres & Director 1963
Mr. Richard J. Buchholz Chief Financial Officer 1968
Mr. Philip J. Ebeling Chief Operating Officer 1971
Mr. Bryan K. Phillips Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. 1971
Mr. Randall A. Ban Chief Commercial Officer 1965
Mr. John C. Rondoni Chief Technology Officer NA
Mr. Martin A. Abrams VP of Marketing & Customer Experience NA
Mr. Steven L. Jandrich VP of HR 1967
Mr. Ivan Lubogo Sr. VP of U.S. Sales NA
Mr. Andreas Henke Sr. VP & MD of Europe NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DHT-U
CAD 13.53
+16.44%
LIF
CAD 22.04
+8.62%
TOI
CAD 103.80
+7.09%
CRON
CAD 5.26
+6.69%
CIA
CAD 2.04
+6.25%
ITH
CAD 1.61
-34.02%
IFOS
CAD 1.65
-22.90%
TNZ
CAD 49.70
-19.58%
KEEL
CAD 2.36
-19.45%
GIL
CAD 49.36
-18.33%

Equity Sectors*

  • Basic Materials

    -2.18%

  • Communication Services

    +0.95%

  • Consumer Cyclical

    -2.25%

  • Consumer Defensive

    -0.68%

  • Energy

    -2.93%

  • Financial Services

    -2.26%

  • Healthcare

    -0.46%

  • Industrials

    -3.70%

  • Real Estate

    -0.06%

  • Technology

    -3.32%

  • Utilities

    -0.50%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…